Login to Your Account



Patchwork tilt? Corium's Aricept PK data hinting skin win after Japan fail

By Randy Osborne
Staff Writer

Thursday, February 4, 2016

With a possible fix for compliance and side-effect issues in Alzheimer's disease, Corium International Inc. drew attention from Wall Street by way of positive top-line phase I data.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription